MedTrace Logo

The Asian Pacific TAVR Multicenter Registry

NCT02195102 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2014-11-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical outcomes of transcatheter aortic valve Replacement (TAVR) in the Asian Pacific population

Conditions

  • Aortic Valve Stenosis

Interventions

DEVICE

Transcatheter aortic valve Replacement

Sponsors & Collaborators

  • Asan Medical Center

    collaborator OTHER

  • Cardiovascular Clinical Research

    collaborator INDUSTRY

  • Michael Kang-Yin Lee, MD

    lead OTHER

Principal Investigators

  • Seung-jung Park, MD, PhD · Asan Medical Center, Republic of Korea

  • Edgar L.W. Tay, MD · National University Heart Center (National University Health System), Singapore

  • Machael Kang-Yin Lee, MD · Queen Elizabeth Hospital, HongKong

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2021-08-31
Completion
2021-12-31

Countries

  • China
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02195102 on ClinicalTrials.gov